LONDON, UK / ACCESSWIRE / May 5, 2022 / Apollon Formularies plc (AQSE:APOL) ("Apollon" or the "Company"), a UK based…
The IND application for this pilot trial to evaluate oral growth hormone secretagogue, LUM-201, in NAFLD has been approved by…
- $209.7 Million Cash and Cash Equivalents at March 31, 2022 – - Over 120 Patients Now Enrolled in Phase…
Point-of-care cardiac screening solution honored at sixth annual awards program for improving detection of heart disease Eko MedTech Breakthrough Award…
Strategic Expansion of Turning Point Precision Oncology Portfolio TPX-4589 (LM-302) Currently in Two Ongoing Phase 1 Studies Agreement Includes Potential…
Highlights: Revenue of $164.9 million for the quarter ended March 31, 2022 Excluding revenue from divested businesses, revenue increased 11%…
Indiana Spine Hospital is the first to utilize the HOLO Portal system, the world’s first artificial intelligence (AI) and augmented…
Developed in partnership with J.P. Morgan and Johnson & Johnson Innovation, the Conference will bring together more than 500 life…
VANCOUVER, British Columbia, May 05, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure…
Nes-Ziona, Israel, May 05, 2022 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy…